An Open-Label, Dose-Escalation, Phase I Clinical Study to Assess the Safety of PI-0824 in Patient With Pemphigus Vulgaris Requiring Daily Corticosteroid Therapy
The purpose of this study is to determine if the use of PI-0824 in patients with Pemphigus vulgaris is safe.